Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


GREY:CLAZF - Post by User

Post by Dude51on Jun 18, 2021 8:31pm
511 Views
Post# 33415800

Think were waiting on ATO. Then up up and away...

Think were waiting on ATO. Then up up and away...that, from my understanding, is, "early next month". We will be watching.

So on the RS you know where not dropping much at this stage of the game, .025 to .035 average. But if you implemnet the RS we go to 50 cents and its free willy to drive share price right back down. If you have deep pockets and are corrupt no problem sabataging a  company with great potential for their own greed, their scum.  Sorry, I digress, my guess is the Robert is just waiting for ATO and maybe other anoucements. If we don't rise significantly after ATO anouncement etc then the Robert will implement RS and start praying...lol

There is no guarantees stock won't dive after RS, keep that in mind, odds slightly better, all depends on phase 1 completion and awesome results there and that is what keeps me in the game. GLA
<< Previous
Bullboard Posts
Next >>